A comparative clinical study of two drugs, shirishadi malahara and yashtimadhu taila in skin itching, burning sensation and stretch marks from 7 th month to 8 th month.

A comparative clinical study of shirishadi malahara and yashtimadhu taila in mangement of kikkisa with respect to striae gravidarum.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039505

Enrollment

Registered

2022-01-18

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P00-P96- Certain conditions originating in the perinatal period

Interventions

Intervention1: Shirishadi malahara in kikkisa: Shirishadi malahara 100gm in kikkisa for 3 months from 7th to 9th month for external application over abdomen Control Intervention1: Yashtimadhu taila in

Eligibility

Inclusion criteria

Inclusion criteria: Pregnent women of age between 18-35years Primi gravid with 28 th week of pregnancy Patient having diagnostic criteria of kikkisa

Exclusion criteria

Exclusion criteria: pregnant women with multiple pregnancies diagnosed case of skin diseases

Design outcomes

Primary

Measure	Time frame
Reduce the symptoms of kikkisaTimepoint: 3 months	—

Secondary

Measure	Time frame
Reduction in burning sensation and itchingTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr PRATHIMA

SDM college of Ayurveda And Hospital Hassan

drprathima@sdmcahhassan.org9611990497

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026